What's New

Foundation Awards Oncology Professionals for Research on Improving Quality of Patient Care

August 28, 2013

CONTACT: Kate Blackburn
Phone: (571) 483-1379

ALEXANDRIA,Va. – The Conquer Cancer Foundation of the American Society of Clinical Oncology announced today the recipients of the 2013 Conquer Cancer Foundation of ASCO Merit Awards in Quality Care. Fourteen award recipients will have the opportunity to present their research and interact with other clinical investigators at ASCO’s 2013 Quality Care Symposium taking place November 1-2 in San Diego, CA.

“Oncologists are keenly focused on providing cancer care of the highest quality. Simply stated, our patients deserve nothing less. Research and innovation related to the quality of care is vitally important, and directly impacts patient care on a day-to-day basis,” said W. Charles Penley, MD, FASCO, Chair of the Conquer Cancer Foundation Board of Directors. “The Conquer Cancer Foundation is proud to honor researchers who are making strides in measuring quality and improving outcomes.”

The Conquer Cancer Foundation of ASCO Merit Award recipients are selected based on the scientific merit of their abstracts and receive funding to help with travel expenses to attend the Symposium. The 2013 awardees have conducted a wide range of research focusing on topics such as access to after-hours care, palliative care training, flu vaccine rates in pediatric patients with cancer, and patient safety during radiation.

The 2013 Merit Award in Quality Care recipients and their abstracts are:

  • Henry Conter, MD, MSc, The University of Texas MD Anderson Cancer Center
    A rapid method to estimate the value of genetic analysis of excised cancers: A comparison in the phase I setting.  (Abstract 264)

  • Andrea Covelli, MD, PhD,  University of Toronto
    Taking control of cancer: Women’s choice for mastectomy. (Abstract 11)

  • Brendan, Curley, DO, MPH, Mary Babb Randolph Cancer Center at West Virginia University
    Palliative care training: A national survey of U.S. hematology/oncology fellows. (Abstract 28)

  • Aaron Falchook, MD, The University of North Carolina at Chapel Hill
    Guideline discordance in the use of radiographic imaging during initial workup of patients with prostate cancer (CaP). (Abstract 109)

  • Jason Freedman, MD, Children’s Hospital of Philadelphia
    Improving the rate of influenza vaccination in pediatric patients with cancer. (Abstract 49)

  • Clement Ho, MD, MSc, Tom Baker Cancer Centre
    A population-based study examining the impact of a multidisciplinary rapid access clinic on utilization of initial treatment options for patients with localized prostate cancer. (Abstract 15)

  • Ankit Kansagra, MD, Baystate Medical Center
    Risk factors for the development of chemotherapy-related hospitalization (CRH) in patients treated with palliative intent: Results of a 9-year nested case control study. (Abstract 3)

  • Kate Lathrop, MD, University of Texas Health Science Center at San Antonio
    Breast cancer treatment delays in a majority minority community: Is there a difference? (Abstract 83)

  • Aparna Parikh, MD, MS, University of California San Francisco
    How is KRAS testing associated with treatment and supportive care for patients with metastatic colorectal cancer? VA national assist project. (Abstract 64)

  • Manali Patel, MD, MPH, Stanford University Medical Center
    Are patients’ needs being met after hours?  An evaluation of phone calls made after hours for patients with thoracic malignancies. (Abstract 46)

  • Anjana Ranganathan, MD, Abramson Cancer Center of the University of Pennsylvania
    Improving code status documentation as a marker of advanced care panning at an outpatient academic cancer center: A pilot project. (Abstract 38)

  • Arvind Shinde, MD, City of Hope
    An interdisciplinary model for predicting patients at high risk for readmission amongst solid tumor oncology patients in a comprehensive cancer center. (Abstract 190)

  • Gary Walker, MD, MPH, Baylor College of Medicine
    Improving patient safety: Factors leading to radiation therapy events in a large academic institution. (Abstract 224)

  • Tian Zhang, MD, Duke University
    Comparison of QOPI measure conformance between oncology fellows and attending physicians. (Abstract 162)

The Conquer Cancer Foundation is celebrating the 30th anniversary of its Grants and Awards Program this year.
Learn more about this milestone and how you can join the Foundation’s efforts to support the next 30 years.

ASCO’s 2013 Quality Care Symposium Merit Awards are supported by: Amgen; Bristol-Myers Squibb; Celgene Corporation; Gilead Sciences, Inc.; Lilly USA, LLC; Millennium: The Takeda Oncology Company; N-of-One; Novartis Oncology; Onyx Pharmaceuticals; and Susan G. Komen®.